Computed tomographic features of pulmonary and extrapulmonary lesions can be useful in prioritizing the diagnosis of hemangiosarcoma metastases in dogs
American Journal of Veterinary Research · 2024
DOI: 10.2460/ajvr.24.08.0219 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2024. Verfasst von Mirko Mattolini und 7 weiteren Autor:innen. Beteiligte Einrichtung: AniCura Clinica Veterinaria Dell'Orologio, Sasso Marconi, Bologna, Italy. Hauptthemen laut MEDLINE: Hemangiosarcoma, Dog Diseases, Lung Neoplasms, Tomography, X-Ray Computed. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
OBJECTIVE The aim of this study was to evaluate the CT features of pulmonary metastases in dogs with hemangiosarcoma (HSA) at various sites. Additionally, the CT characteristics of extrapulmonary metastases in the same population were assessed. METHODS Retrospective, observational, and descriptive study conducted from April 2013 to January 2024. Dogs with histologically confirmed HSA and suspected or cytologically/histologically confirmed lung metastases were included. Dogs were excluded if they had a second primary tumor or only 1 unsampled pulmonary nodule. RESULTS 33 dogs were included, with 26/33 [78.8%] having more than 10 metastatic pulmonary nodules. Most nodules were generalized (24/33 [72.7%]), miliary (29/33 [87.9%]) to subcentimetric (32/33 [97%]) in size, well-defined margins (29/33 [87.9%]), or a perilesional halo sign (24/33 [72.7%]). When more than 10 nodules were present, a generalized distribution was prevalent, while a peripheral location was more common when 2 to 10 nodules were present ( P < .0001). In 32/33 (97%) cases, a pulmonary vessel was directly connected to the nodule (feeding vessel). After contrast administration, most lung metastases appeared homogenous (26/33 [78.8%]), although some showed areas of intense enhancement (5/33 [15.1%]) a feature also observed in extrapulmonary metastases with varying frequency (0% to 85.7%). CONCLUSIONS Pulmonary HSA metastases were characterized by generalized, small (miliary/subcentimetric), well-defined nodules, commonly associated with a halo sign and feeding vessel. Intralesional areas of spotty postcontrast linear or amorphous strong hyperdensity were frequently observed especially in extrapulmonary metastases. CLINICAL RELEVANCE These features may help radiologists and clinicians orient their diagnosis toward metastatic HSA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- AniCura Clinica Veterinaria Dell'Orologio, Sasso Marconi, Bologna, Italy.
- Department of Veterinary Sciences, University of Pisa, San Piero a Grado, Pisa, Italy.
ORCID-Profile: Mirko Mattolini, Simonetta Citi, Roberta Franchi, Valentina Meucci, Gregorio Carozzi, Beatrice Gianni, Elvanessa Caleri, Federica Rossi
Zitieren
APA
Mattolini, M., Citi, S., Franchi, R., Meucci, V., Carozzi, G., Gianni, B., Caleri, E., & Rossi, F. (2024). Computed tomographic features of pulmonary and extrapulmonary lesions can be useful in prioritizing the diagnosis of hemangiosarcoma metastases in dogs. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.24.08.0219
Vancouver
Mattolini M, Citi S, Franchi R, Meucci V, Carozzi G, Gianni B, et al. Computed tomographic features of pulmonary and extrapulmonary lesions can be useful in prioritizing the diagnosis of hemangiosarcoma metastases in dogs. American Journal of Veterinary Research. 2024. doi:10.2460/ajvr.24.08.0219
BibTeX
@article{Mattolini2024,
author = {Mattolini, Mirko and Citi, Simonetta and Franchi, Roberta and Meucci, Valentina and Carozzi, Gregorio and Gianni, Beatrice and Caleri, Elvanessa and Rossi, Federica},
title = {Computed tomographic features of pulmonary and extrapulmonary lesions can be useful in prioritizing the diagnosis of hemangiosarcoma metastases in dogs},
journal = {American Journal of Veterinary Research},
year = {2024},
doi = {10.2460/ajvr.24.08.0219}
}
EUVIMED